Intuitive Surgical, Inc. $ISRG Shares Purchased by Laffer Tengler Investments Inc.

Laffer Tengler Investments Inc. boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 80.0% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,125 shares of the medical equipment provider’s stock after buying an additional 500 shares during the quarter. Laffer Tengler Investments Inc.’s holdings in Intuitive Surgical were worth $611,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of the stock. Vanguard Group Inc. increased its position in Intuitive Surgical by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after purchasing an additional 453,335 shares in the last quarter. Invesco Ltd. lifted its holdings in Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after purchasing an additional 71,794 shares in the last quarter. Northern Trust Corp boosted its stake in shares of Intuitive Surgical by 0.3% during the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after purchasing an additional 11,988 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares during the last quarter. Finally, Nuveen LLC purchased a new stake in shares of Intuitive Surgical during the first quarter worth about $1,715,899,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Piper Sandler upped their price objective on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $685.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, October 21st. Finally, Wells Fargo & Company upped their target price on Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $560.00 on Monday. The stock has a 50-day simple moving average of $471.89 and a 200-day simple moving average of $501.11. The stock has a market capitalization of $200.75 billion, a P/E ratio of 74.07, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the previous year, the company posted $1.84 earnings per share. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. Analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity

In related news, insider Gary S. Guthart sold 2,800 shares of the stock in a transaction on Friday, October 24th. The stock was sold at an average price of $546.27, for a total value of $1,529,556.00. Following the completion of the sale, the insider directly owned 17,120 shares in the company, valued at approximately $9,352,142.40. This represents a 14.06% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Craig H. Barratt sold 2,193 shares of the business’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $548.01, for a total value of $1,201,785.93. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 98,078 shares of company stock worth $51,445,892 in the last quarter. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.